ArticleTranslational pediatrics2026

Fremanezumab for episodic migraine in children and adolescents: the evolving landscape of CGRP-targeted therapies.

Paige Kalika et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.